Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
2.
Rev Stomatol Chir Maxillofac ; 106(3): 177-80, 2005 Jun.
Artigo em Francês | MEDLINE | ID: mdl-15976707

RESUMO

INTRODUCTION: Ameloblastoma is a benign odontogenic tumor which can be locally aggressive and invasive. Metastases are rare but possible and must be considered as a malignant form of the tumor. OBSERVATION: A 50-year-old woman presented a jugal metastasis of a mandibular ameloblastom which had been treated several times 28 years earlier. Six months after resection of the metastasis, the patient developed multiple cervical node metastases which were removed by radical curettage. Five months later, new metastases developed on the scalp and three months later a voluminous metastasis involving the right hemiface extended to the base of the skull. Surgical resection was only partial followed by radiotherapy. Ten months later the outcome was favorable. DISCUSSION: The absence of any histological sign of malignity in the primary tumor and in the metastases, as observed in our patient, is remarkable. Metastases generally develop in the lung (61-80% of cases). Metastases to the scalp have never been described. The time to development of a metastasis is generally very long and metastases usually remain asymptomatic. Progression is very slow, like for the primary tumor. Several factors predictive of metastasis have been described: female gender, age at onset of primary tumor (2nd to 3rd decade) and multiple local recurrences. There is no standard treatment for metastases. Chemotherapy is not effective. Radiotherapy may be effective, particularly when lesions are not accessible to surgery. Surgical resection remains the treatment of choice.


Assuntos
Ameloblastoma/secundário , Neoplasias Mandibulares/patologia , Ameloblastoma/patologia , Feminino , Seguimentos , Neoplasias de Cabeça e Pescoço/secundário , Humanos , Metástase Linfática/patologia , Pessoa de Meia-Idade , Neoplasias dos Seios Paranasais/secundário , Couro Cabeludo/patologia , Neoplasias Cutâneas/secundário , Neoplasias Cranianas/secundário , Zigoma/patologia
3.
Br J Ophthalmol ; 85(12): 1406-10, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11734509

RESUMO

BACKGROUND: Evidence of widespread distribution of trachoma in Egypt had not been clarified as previous surveys were limited to individual communities which may not have been representative of the general population. The Nile Delta of Egypt presents a unique environment for trachoma to persist. Economic improvements in the past decade have affected even the poorest rural environments; availability of electricity is now found in many rural communities. Availability of water in Nile Delta has always been good but poor hygienic conditions have been the primary factor in trachoma transmission. A survey of trachoma was undertaken in Menofiya governorate to determine if Egypt should be identified as trachoma endemic and targeted for trachoma control efforts. METHODS: A multistage random cluster study design was used with the target population defined as adults aged 50 and over and children aged 2-6 years from throughout the governorate. Among preschool children only trachoma was graded while among adults presenting visual acuity and cause of vision loss or blindness were also recorded. Adults were interviewed regarding past trichiasis surgery; those currently with trichiasis or a history of trichiasis surgery were also interviewed regarding outcome of surgery. RESULTS: A total of 3272 children aged 2-6 and 3322 adults age 50+ were enumerated. Among the children 81.3% were examined and among the adults 73.0% were examined. Active trachoma (follicles (TF) and/or intense inflammation (TI)) was found among 36.5% (95% confidence interval (CI) 34.7-38.3%) of the children. TI was 1.89 (95% CI 1.22-2.94) times more common in rural children compared to urban children. The prevalence of trichiasis (TT) in adults was 6.5%; women had an age adjusted odds of trichiasis of 1.68 (95% CI 1.18-2.39) compared to men. Trichiasis was 2.11 times (95% CI 1.33-3.37) more common in rural Menofiya compared to urban Menofiya. TT accounts for blindness (presenting vision <3/60) in 8% of patients and accounts for 13.2% of visual impairment. Overall, trichiasis surgical coverage was 34.4%, slightly higher among men than women. The outcome of trichiasis surgery was poor in 44.4% of cases. CONCLUSION: Trachoma is a serious public health problem in Menofiya governorate and a significant contributor to vision loss. These findings would suggest that continued poor hygienic conditions in rural Egypt have limited the reduction of active trachoma even in the face of significant improvements in socioeconomic status. Furthermore, the high proportion of trichiasis surgery cases with a poor outcome would indicate a need to reassess current surgical practices in Egypt and improve training and monitoring.


Assuntos
Países em Desenvolvimento/estatística & dados numéricos , Tracoma/epidemiologia , Idoso , Cegueira/epidemiologia , Cegueira/microbiologia , Criança , Pré-Escolar , Cicatriz/microbiologia , Análise por Conglomerados , Doenças da Túnica Conjuntiva/microbiologia , Egito/epidemiologia , Meio Ambiente , Doenças Palpebrais/microbiologia , Doenças Palpebrais/cirurgia , Acessibilidade aos Serviços de Saúde , Inquéritos Epidemiológicos , Humanos , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Tracoma/complicações
4.
J Org Chem ; 66(11): 4055-7, 2001 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-11375036
5.
Trop Med Int Health ; 3(9): 721-7, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9754667

RESUMO

We performed a series of ELISAs to evaluate the diagnostic significance of two Schistosoma mansoni proteins, Sm31 (cysteine proteinase, cathepsin B) and Sm32 (asparaginyl endopeptidase). Our study populations were chosen from two villages in an endemic area close to Alexandria. Using fusion proteins MS2-Sm31 and MS2-Sm32 as antigens, 70% and 78.9%, respectively, of patient sera from 134 parasitologically confirmed cases reacted positively. The percentage of seropositivity increased to 84.5% when parasite-derived proteins Sm31 and Sm32 were used. The serum levels of antibodies to these two proteins in recombinant or native forms do not correlate with intensity of infection and hence are detected even when egg counts are low, which makes proteins Sm31 and Sm32 useful antigens in the identification of S. mansoni infected cases, particularly in endemic areas in Egypt.


Assuntos
Anticorpos Anti-Helmínticos/sangue , Antígenos de Helmintos/imunologia , Cisteína Endopeptidases/imunologia , Doenças Endêmicas , Proteínas de Helminto/imunologia , Proteínas de Plantas , Schistosoma mansoni/imunologia , Esquistossomose mansoni/diagnóstico , Esquistossomose mansoni/imunologia , Adolescente , Adulto , Animais , Estudos de Casos e Controles , Criança , Pré-Escolar , Egito/epidemiologia , Ensaio de Imunoadsorção Enzimática , Fezes/parasitologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Contagem de Ovos de Parasitas , Reprodutibilidade dos Testes , Esquistossomose mansoni/epidemiologia , Sensibilidade e Especificidade , Estudos Soroepidemiológicos , Índice de Gravidade de Doença
6.
J Am Acad Dermatol ; 37(5 Pt 1): 740-5, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9366820

RESUMO

BACKGROUND: Onychomycosis is an increasing problem with limited therapeutic options. OBJECTIVE: We evaluated the safety and efficacy, of oral terbinafine, a new fungicidal antimycotic, in patients with toenail onychomycosis. METHODS: A North American multicenter, double-blind, placebo-controlled study evaluated the mycologic and clinical efficacy of oral terbinafine 250 mg/day for 12 or 24 weeks in 358 patients with toenail onychomycosis. RESULTS: A total of 74% of patients treated with 12 or 24 weeks of terbinafine achieved a successful clinical outcome. Approximately 11% of terbinafine responders showed evidence of relapse 18 of 21 months after cessation of treatment. Terbinafine was well tolerated; most adverse events were transient and mild to moderate in severity. CONCLUSION: The results of this study confirm that oral terbinafine is a safe and effective therapy for the treatment of onychomycosis.


Assuntos
Antifúngicos/uso terapêutico , Naftalenos/uso terapêutico , Onicomicose/tratamento farmacológico , Dor Abdominal/induzido quimicamente , Administração Oral , Adulto , Idoso , Antifúngicos/efeitos adversos , Diarreia/induzido quimicamente , Método Duplo-Cego , Toxidermias/etiologia , Epidermophyton/isolamento & purificação , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Naftalenos/efeitos adversos , Onicomicose/diagnóstico , Onicomicose/microbiologia , Recidiva , Terbinafina , Dedos do Pé , Trichophyton/isolamento & purificação
9.
Arch Dermatol ; 125(12): 1685-8, 1989 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2556081

RESUMO

Acute graft-vs-host disease occurring during the early weeks of life has been previously reported as a rare disease entity. We report a case of acute graft-vs-host disease in a female infant with an immunodeficiency that was thought to be secondary to intrauterine or neonatal cytomegalovirus infection or, less likely, to a severe combined immunodeficiency. The patient presented with a triad of failure to thrive, diarrhea, and maculopapular and petechial rash. The first clue to diagnosis was the skin biopsy finding of an epidermal lymphocytic infiltrate in association with individual necrotic keratinocytes. The diagnosis was confirmed at autopsy. In the absence of an obvious graft, the disease is believed to have been the result of maternofetal T-cell transfer in utero or at delivery.


Assuntos
Infecções por Citomegalovirus/complicações , Doença Enxerto-Hospedeiro , Síndromes de Imunodeficiência/complicações , Feminino , Doença Enxerto-Hospedeiro/complicações , Doença Enxerto-Hospedeiro/etiologia , Doença Enxerto-Hospedeiro/patologia , Humanos , Síndromes de Imunodeficiência/etiologia , Lactente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...